Compounds > raloxifene hydrochloride
Page last updated: 2024-08-23

raloxifene hydrochloride and thyroxine

raloxifene hydrochloride has been researched along with thyroxine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duntas, LH; Koutras, DA; Mantzou, E1
Cheng, WC; Hsu, SH; Jang, MW; Tsai, KS1
Gupta, MK; Reddy, SS; Siraj, ES1
Crans, G; Eppel, W; Jirecek, S; Lee, A; Pavo, I; Wenzl, R1
Matsuno, A; Okazaki, R; Okinaga, H1
Garwood, CL; McDonough, RP; Sullivan, AL; Van Schepen, KA1

Trials

3 trial(s) available for raloxifene hydrochloride and thyroxine

ArticleYear
Lack of substantial effects of raloxifene on thyroxine-binding globulin in postmenopausal women: dependency on thyroid status.
    Thyroid : official journal of the American Thyroid Association, 2001, Volume: 11, Issue:8

    Topics: Aged; Bone Diseases, Metabolic; Dose-Response Relationship, Drug; Female; Humans; Kinetics; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Reference Values; Selective Estrogen Receptor Modulators; Thyroid Gland; Thyrotropin; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine

2001
Effects of long-term use of raloxifene, a selective estrogen receptor modulator, on thyroid function test profiles.
    Clinical chemistry, 2001, Volume: 47, Issue:10

    Topics: Adult; Aged; Double-Blind Method; Estradiol; Female; Follicle Stimulating Hormone; Humans; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Thyroxine-Binding Proteins

2001
Raloxifene prevents the growth of uterine leiomyomas in premenopausal women.
    Fertility and sterility, 2004, Volume: 81, Issue:1

    Topics: Adult; Estradiol; Female; Follicle Stimulating Hormone; Humans; Leiomyoma; Middle Aged; Premenopause; Prolactin; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Testosterone; Thyrotropin; Thyroxine; Ultrasonography; Uterine Neoplasms

2004

Other Studies

3 other study(ies) available for raloxifene hydrochloride and thyroxine

ArticleYear
Raloxifene causing malabsorption of levothyroxine.
    Archives of internal medicine, 2003, Jun-09, Volume: 163, Issue:11

    Topics: Absorption; Aged; Drug Interactions; Female; Humans; Hypothyroidism; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thyroxine

2003
High risk of osteopenia and bone derangement in postsurgical patients with craniopharyngiomas, pituitary adenomas and other parasellar lesions.
    Endocrine journal, 2005, Volume: 52, Issue:6

    Topics: Adolescent; Adult; Aged; Bone Density; Bone Diseases, Metabolic; Bone Resorption; Child; Collagen; Collagen Type I; Craniopharyngioma; Diphosphonates; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Hydrocortisone; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Peptides; Pituitary Neoplasms; Raloxifene Hydrochloride; Risk Factors; Testosterone; Thyroxine

2005
Increased thyroid-stimulating hormone levels associated with concomitant administration of levothyroxine and raloxifene.
    Pharmacotherapy, 2006, Volume: 26, Issue:6

    Topics: Drug Interactions; Female; Humans; Hypothyroidism; Middle Aged; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thyrotropin; Thyroxine

2006